UNVERIFIEDSingle Source
STAT+: Travere’s drug for a kidney disease doesn’t improve kidney function. The FDA approved it anyway
Stat News|4/16/2026
B
Biotech
363 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
182
Activity (Last 30 Days)
4
2
5
2
3
1
3
5
4
5
1
3
4
2
3
3
4
3
2
2
2
1
2026-03-232026-04-19
Top Publishers
Stat News172 stories
WSJ4 stories
Google News2 stories
San Francisco Chronicle1 stories
Nature1 stories
Stories (Latest First)
UNVERIFIEDSingle Source
STAT+: Spyre Therapeutics IBD drug shows promise in early trial
Stat News|4/13/2026
UNVERIFIEDSingle Source
STAT+: Replimune skin cancer drug that became FDA flashpoint is rejected again
Stat News|4/10/2026
UNVERIFIEDSingle Source
STAT+: Terns’ drug may not be as competitive as many initially thought
Stat News|4/8/2026
UNVERIFIEDSingle Source
STAT+: Many cancer patients don’t get genomic tests to guide treatment, study finds
Stat News|4/7/2026
UNVERIFIEDSingle Source
STAT+: Neurocrine Biosciences to buy Soleno Therapeutics in $2.9B deal
Stat News|4/6/2026
UNVERIFIEDSingle Source
STAT+: Psychedelic biotechs face scrutiny over YouTube promos
Stat News|3/31/2026
UNVERIFIEDSingle Source
STAT+: Biogen to acquire immunology biotech Apellis for $5.6 billion
Stat News|3/31/2026
UNVERIFIEDSingle Source
STAT+: FDA approves Rocket gene therapy for rare immune disorder
Stat News|3/27/2026
UNVERIFIEDSingle Source
STAT+: Allogene’s off-the-shelf CAR-T is nearing an early but pivotal study readout
Stat News|3/26/2026
UNVERIFIEDSingle Source
STAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drug
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: Gilead to acquire immunology biotech, offers lifeline to Galapagos
Stat News|3/24/2026
UNVERIFIEDSingle Source
STAT+: Insmed drug benefits patients with rare, bacterial lung disease, study shows
Stat News|3/23/2026
UNVERIFIEDSingle Source
Drug development is booming in China. Should the U.S. view it as a threat or an opportunity?
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: Eli Lilly’s ‘triple-G’ drug leads to significant blood sugar, weight reductions in diabetes trial
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: Six drugmakers, six months: Charting the FDA’s course in the post-Prasad era
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: J&J wins approval for first-of-its-kind psoriasis pill
Stat News|3/18/2026
UNVERIFIEDSingle Source
Analysis of Medicare data shows who mental health providers treat over telehealth
Stat News|3/12/2026
UNVERIFIEDSingle Source
STAT+: A top biotech VC quietly helped Epstein’s ‘great friend’ make a comeback
Stat News|3/11/2026
UNVERIFIEDSingle Source
STAT+: Vertex says its drug successfully reduced marker of kidney disease in late-stage trial
Stat News|3/9/2026
UNVERIFIEDSingle Source
STAT+: Servier to acquire Day One, maker of pediatric cancer drug, for $2.5B
Stat News|3/6/2026
UNVERIFIEDSingle Source
STAT+: The extremism of the FDA’s Marks and Prasad has come with costs
Stat News|3/5/2026
UNVERIFIEDSingle Source
STAT+: Prime Medicine to seek approval for gene editing treatment after two-patient trial
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: CMS wants more drugmakers to join Medicaid ‘most-favored nations’ pilot
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: FDA is ‘not convinced’ UniQure’s Huntington’s therapy has benefit, senior official says
Stat News|3/3/2026
UNVERIFIEDSingle Source
STAT+: UniQure plans to seek approval for Huntington’s therapy still blocked by FDA
Stat News|3/2/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk strikes deal with U.S. startup to develop oral obesity, diabetes drugs
Stat News|2/25/2026
UNVERIFIEDSingle Source
STAT+: Drugmakers lay out their legal arguments against Trump’s drug pricing experiments
Stat News|2/24/2026
UNVERIFIEDSingle Source
STAT+: New treatment approach could give IBD patients hope, and be a bonanza for drugmakers
Stat News|2/24/2026
UNVERIFIEDSingle Source
STAT+: Gossamer lung disease drug fails late-stage study, but company will still seek FDA approval
Stat News|2/23/2026
UNVERIFIEDSingle Source
STAT+: Key study of Grail’s cancer detection test fails in setback for company
Stat News|2/19/2026
UNVERIFIEDSingle Source
STAT+: In first speech to her FDA staff, Høeg says she’ll scrutinize RSV shots and SSRIs in pregnancy
Stat News|2/19/2026
UNVERIFIEDSingle Source
STAT+: FDA’s rejection of Moderna threatens to stifle broader vaccine industry
Stat News|2/12/2026
UNVERIFIEDSingle Source
STAT+: ‘Moonshot’ agency ARPA-H lays off staff meant to commercialize breakthroughs
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: White House looks for more drug pricing deals to add to TrumpRx
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: Roivant immune drug significantly outperformed placebo in treating rare skin disease
Stat News|2/6/2026
UNVERIFIEDSingle Source
STAT+: Trump administration officials blocked FDA effort to fast-track review of psychedelic treatment
Stat News|2/4/2026
UNVERIFIEDSingle Source
STAT+: FDA officials push for long-term monitoring of autoimmune patients receiving CAR-T therapy
Stat News|2/2/2026
UNVERIFIEDSingle Source
STAT+: Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s
Stat News|2/2/2026